Carmela Pisano

4.8k total citations
95 papers, 1.9k citations indexed

About

Carmela Pisano is a scholar working on Reproductive Medicine, Oncology and Surgery. According to data from OpenAlex, Carmela Pisano has authored 95 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Reproductive Medicine, 43 papers in Oncology and 26 papers in Surgery. Recurrent topics in Carmela Pisano's work include Ovarian cancer diagnosis and treatment (66 papers), Endometrial and Cervical Cancer Treatments (24 papers) and PARP inhibition in cancer therapy (18 papers). Carmela Pisano is often cited by papers focused on Ovarian cancer diagnosis and treatment (66 papers), Endometrial and Cervical Cancer Treatments (24 papers) and PARP inhibition in cancer therapy (18 papers). Carmela Pisano collaborates with scholars based in Italy, France and Germany. Carmela Pisano's co-authors include Sandro Pignata, Sabrina Chiara Cecere, Marilena Di Napoli, Gaetano Facchini, Simona Losito, Rosa Tambaro, G. Bruni, Giovanni Scambia, Chiara Della Pepa and Stefano Greggi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Carmela Pisano

91 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmela Pisano Italy 26 862 706 532 447 321 95 1.9k
Marta A. Crispens United States 25 723 0.8× 498 0.7× 568 1.1× 447 1.0× 177 0.6× 62 1.8k
Vanda Salutari Italy 23 722 0.8× 555 0.8× 333 0.6× 412 0.9× 291 0.9× 110 1.5k
Sharad Ghamande United States 22 476 0.6× 770 1.1× 579 1.1× 333 0.7× 199 0.6× 114 1.7k
Scott McMeekin United States 22 867 1.0× 424 0.6× 541 1.0× 517 1.2× 469 1.5× 37 1.9k
Sabrina Chiara Cecere Italy 20 525 0.6× 615 0.9× 428 0.8× 261 0.6× 227 0.7× 71 1.4k
Rosalind Glasspool United Kingdom 25 753 0.9× 722 1.0× 842 1.6× 375 0.8× 181 0.6× 86 1.9k
Kyle C. Strickland United States 20 491 0.6× 957 1.4× 485 0.9× 324 0.7× 413 1.3× 72 2.2k
Fabian Trillsch Germany 25 712 0.8× 577 0.8× 802 1.5× 456 1.0× 389 1.2× 128 2.1k
Toshiko Jobo Japan 20 1.1k 1.2× 636 0.9× 294 0.6× 717 1.6× 410 1.3× 70 1.8k
M. Baekelandt Norway 24 664 0.8× 525 0.7× 437 0.8× 426 1.0× 308 1.0× 55 1.4k

Countries citing papers authored by Carmela Pisano

Since Specialization
Citations

This map shows the geographic impact of Carmela Pisano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmela Pisano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmela Pisano more than expected).

Fields of papers citing papers by Carmela Pisano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmela Pisano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmela Pisano. The network helps show where Carmela Pisano may publish in the future.

Co-authorship network of co-authors of Carmela Pisano

This figure shows the co-authorship network connecting the top 25 collaborators of Carmela Pisano. A scholar is included among the top collaborators of Carmela Pisano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmela Pisano. Carmela Pisano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valabrega, Giorgio, Ignace Vergote, Debra L. Richardson, et al.. (2025). Longer-Term Safety And Efficacy Of Selinexor Maintenance Therapy For Patients With TP53wt Advanced Or Recurrent Endometrial Cancer: Follow-Up Subgroup Analysis Of The ENGOT-EN5/GOG-3055/SIENDO Study. International Journal of Gynecological Cancer. 35(2). 100081–100081. 1 indexed citations
2.
Cecere, Sabrina Chiara, Marilena Di Napoli, Jole Ventriglia, et al.. (2024). Endometrial cancer in the elderly: Characteristics, prognostic and risk factors, and treatment options. Critical Reviews in Oncology/Hematology. 204. 104533–104533. 7 indexed citations
3.
Passarelli, Anna, Jole Ventriglia, Carmela Pisano, et al.. (2023). The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a PIK3CA-mutated endometrial cancer. Frontiers in Oncology. 12. 1088962–1088962. 5 indexed citations
4.
5.
Tambaro, Rosa, Marilena Di Napoli, Carmela Pisano, et al.. (2020). From Clinical Trials to Clinical Use of Checkpoint Inhibitors for Patients With Metastatic Urothelial Cancer. Immunotherapy. 13(1). 67–77. 6 indexed citations
6.
Giorgi, Ugo De, Giuseppe Schepisi, Giorgia Gurioli, et al.. (2020). Olaparib as salvage treatment for advanced germ cell tumors after chemotherapy failure: Results of the open-label, single-arm, IGG-02 phase II trial.. Journal of Clinical Oncology. 38(15_suppl). 5058–5058. 15 indexed citations
7.
Ventriglia, Jole, Carmela Pisano, Rosa Tambaro, et al.. (2020). Arthralgia in patients with ovarian cancer treated with bevacizumab and chemotherapy. International Journal of Gynecological Cancer. 31(1). 110–113. 3 indexed citations
8.
Mangili, Giorgia, Raffaella Cioffi, Saverio Danese, et al.. (2018). Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study. Gynecologic Oncology. 151(3). 449–452. 15 indexed citations
9.
Penson, Richard T., JA Ledermann, Christopher Brown, et al.. (2017). Efficacy of olaparib maintenance therapy in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC) by lines of prior chemotherapy: Phase III SOLO2 trial (ENGOT Ov-21). Annals of Oncology. 28. v331–v331. 4 indexed citations
10.
Ventriglia, Jole, Carmela Pisano, Sabrina Chiara Cecere, et al.. (2017). Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives. Cancer Treatment Reviews. 59. 109–116. 119 indexed citations
11.
Romano, Annunciata, Rosa Pasquinelli, Sandro Pignata, et al.. (2015). Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer. Oncotarget. 6(22). 19328–19335. 17 indexed citations
12.
13.
Gigantino, Vincenzo, Elvira La Mantia, Renato Franco, et al.. (2012). Testicular and testicular adnexa tumors in the elderly. Anti-Cancer Drugs. 24(3). 228–236. 4 indexed citations
14.
Fulciniti, Franco, Simona Losito, Gerardo Botti, et al.. (2009). Fine‐needle cytology of metastatic endometrioid neoplasms: Experience with eight cases. Diagnostic Cytopathology. 37(5). 347–352. 4 indexed citations
15.
Pignata, Sandro, Carmela Pisano, G. Bruni, Gaetano Facchini, & Sandro Pignata. (2009). Treatment of recurrent epithelial ovarian cancer. Therapeutics and Clinical Risk Management. 5(4). 421–421. 28 indexed citations
16.
Pisano, Carmela, Alessandro Morabito, Roberto Sorio, et al.. (2009). A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial. Cancer Chemotherapy and Pharmacology. 64(5). 1021–1027. 7 indexed citations
17.
18.
Pignata, Sandro, Carmela Pisano, Massimo Di Maïo, et al.. (2006). Medical treatment of resistant or recurrent epithelial ovarian cancer. Annals of Oncology. 17. vii49–vii50. 4 indexed citations
19.
Scambia, Giovanni, Massimo Di Maïo, Carmela Pisano, et al.. (2004). The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer. Critical Reviews in Oncology/Hematology. 52(1). 33–44. 23 indexed citations
20.
Greggi, Stefano, R.V. Iaffaioli, Antônio Rossi, et al.. (2003). An escalating dose finding study of liposomal doxorubicin and vinorelbine for the treatment of refractory or resistant epithelial ovarian cancer. Annals of Oncology. 14(9). 1406–1411. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta A. Crispens Breakdown of academic impact, for papers by Vanda Salutari Breakdown of academic impact, for papers by Sharad Ghamande Breakdown of academic impact, for papers by Scott McMeekin Breakdown of academic impact, for papers by Sabrina Chiara Cecere Breakdown of academic impact, for papers by Rosalind Glasspool Breakdown of academic impact, for papers by Kyle C. Strickland Breakdown of academic impact, for papers by Fabian Trillsch Breakdown of academic impact, for papers by Toshiko Jobo Breakdown of academic impact, for papers by M. Baekelandt
Rankless by CCL
2026